Jasper Therapeutics, Inc. Profile Avatar - Palmy Investing

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engine…

Biotechnology
US, Redwood City [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Jasper Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Jasper Therapeutics, Inc. can't present revenue by segment

End of JSPR's Analysis
CIK: 1788028 CUSIP: 471871103 ISIN: US4718712023 LEI: - UEI: -
Secondary Listings
JSPR has no secondary listings inside our databases.